Table of Content Download Sample

Veterinary Pharmaceutical Drugs Market: Information by Disease (Swine Influenza, Osteoarthritis, Newcastle Disease), Drug Types (Swine Drug, Poultry Drug), and Region — Forecast till 2027

Request Free Sample Report

Report Description

The global veterinary pharmaceuticals drugs market was worth USD 41,633.76 million during 2020 and is expected to reach USD 64,796.09 million by 2026 at a CAGR of 7.56%.


To learn more about key trends >> Download Sample Report

The Prevalence of Infectious and Chronic Illnesses Propel the Veterinary Pharmaceuticals Drugs Industry

The rising prevalence of infectious and chronic illnesses is propelling the veterinary medication industry. The global Veterinary Pharmaceutical Drugs Market is expected to increase at a higher CAGR by 2030.

Likewise, the world cattle population has grown swiftly over the last few decades. According to the USDA, there were nearly 103 million cattle and 32.1 million beef cows in the U.S. as of July 2020. These numbers are projected to expand significantly in the coming years.

In addition, increased research and development (R&D) and procedural developments, pet adoption rates, rising meat consumption, and mandated immunization are expected to drive the demand for veterinary medications and vaccines for pets.

Key Insights

The Rising Demand Vaccines, Medical Feed Supplements, Mergers of Key Players Driving the Growth of the Market:

  • Pharmaceuticals led the veterinary medication market in 2020, with a revenue share of over 57% since the prevalence of bacterial infections, brucellosis, and other food-borne infections is increasing.
  • The market is divided into three product categories: biologics, medicines, and medicated food supplements. Biologics are further subdivided into vaccinations and others. I immunomodulatory, monoclonal antibodies, hormone supplements are examples of others.
  • Pharmaceuticals are further classified as anti-infectives, analgesics, parasiticides, anti-inflammatory drugs, and so forth.
  • Due to the growing consumption of vaccines across livestock and companion animals for disease prevention, the biologics sector is expected to expand the quickest in the veterinary medicine market throughout the forecast period. According to CNN, the United Kingdom Department for Environment, Food, and Rural Affairs confirmed the emergence of H5N1 avian flu at a chicken farm in Suffolk. In December 2019, 27,000 birds were slaughtered humanely as a result of the sickness.
  • The medical feed supplements market is also predicted to rise rapidly throughout the forecast period, owing to their growing use in animal health maintenance.
  • The growing worldwide population increases consumption of meat and dairy products, promoting the expansion of the medical feed additives industry.
  • A considerable number of acquisitions and mergers performed by leading market players to extend their product range of vaccines is predicted to improve the growth potential.

Animal Adoption and Product Launches Accelerate Market Growth Dynamics in North America:

The animal medication industry is likely to be driven by the rising adoption of veterinary medication. Essentially, the global veterinary medication sector is unexplored and has low penetration rates, creating a substantial market opportunity. Veterinary medication penetration rates are under 1% in industrialized economies such as the U.S. and around 20% in Western European nations such as the U.K. The veterinary pharmaceuticals drugs industry in the U.S. is predicted to expand from USD 1 billion in 2018 to USD 2 billion in 2022, growing at a higher CAGR due to rising consumer awareness and rising disposable income.

North America dominates the global veterinary medication industry, accounting for more than 37.4% of the market share in 2020. Growth in this region is expected to be driven by increased animal adoption and new and improved products. The consumption of veterinary pharmaceuticals in industrialized nations is expanding due to high animal ownership and rigorous animal healthcare rules. Besides, R&D activities lead to the development of new treatments, increasing the demand further.


To understand geography trends >> Download Sample Report

European nations are gaining ground due to favorable government rules such as the EU Veterinary Medicines Regulation and increased acceptance of pet insurance in Europe. Due to stringent animal health rules, the veterinary pharmaceuticals drugs industry in Europe will continue to rise.

Increasing the use of modern veterinary medications in Asia-Pacific, particularly in developing nations such as India and China, will drive market expansion over the forecast period. Animal health knowledge is growing in Asia-Pacific due to government initiatives, increased use of animals in agriculture, and rising disposable incomes, which leads to higher veterinary medicine spending.

The rising occurrence of zoonotic illnesses and advantageous reimbursement plans are primary contributors to the dominion. According to the Centers for Disease Control and Prevention, zoonotic infections are widespread in the U.S. and across the world. It is believed that 6 out of 10 identified infectious diseases can be transferred by animals, while animals cause 3 out of 4 emerging infections in humans. Further, the rising acceptance of pet health insurance in the U.S. is likely to boost the growth.

The market for veterinary medication in Asia-Pacific is predicted to rise rapidly over the projected period. Factors such as the increased popularity of companion animals and animal health hazards have fueled market expansion in the area. Further, rising expenditure on animal health and veterinary services and an increase in cattle population boost the veterinary medication industry.

Companies Driving the Market and their Shares

In order to stay competitive, market leaders engage in strategic alliances, geographical growth, and new product launches. Established companies and giant corporations acquire other market competitors to obtain a competitive advantage.

Ceva inked a deal with ProBioGen Ag in October 2019 to manufacture vectorized chicken vaccinations utilizing ProBioGen's patented AGE1.CR technologies. It aided both firms in solidifying their long-term collaboration and expertise in creating new vaccines.In 2020, the veterinary hospitals and clinics sector led the Veterinary Pharmaceutical Drugs Market, with a revenue share of more than 72.0 %. The latest diagnostic imaging, innovative therapeutics, nuclear and regenerative medicines, laser diagnostics, and specialist operations offered in veterinary hospitals and clinics are all contributing to the increase.

The release of Poulvac Procerta HVT-ND, a vectored recombinant vaccine for protection against Newcastle and Marek's disease viruses, by Zoetis, a prominent animal health business, in January 2020, greatly increased the company's poultry vaccine range.

Merck bought IdentiGEN, a firm specializing in DNA-based animal traceability solutions for aquaculture and cattle, in August 2020.

Elanco bought Bayer's Animal Health Business in August 2020 to grow Elanco's scale and capabilities, establishing the firm for the long run as a pioneer in the appealing, long-lasting veterinary pharmaceutical drugs industry. Among the leading businesses in the veterinary medicine market are:

  • Elanco
  • Merck Animal Health
  • Vetoquinol S.A.
  • Boehringer Ingelheim GmbH
  • Ceva Sante Animale
  • Zoetis
  • Kindred Biosciences, Inc.
  • Nutreco N.V.
  • Virbac
  • Biogenesis Bago
  • Neogen Corporation
  • Philbro Animal Health
  • Hester Biosciences
  • Indian Immunologicals Ltd.

Global Veterinary Pharmaceutical Drugs Market: Segmentation

This report anticipates growth in revenue at the global, regional, and national levels, along with a study of the most recent industry trends in these sub-segments through 2019 to 2029. Broad View Research has divided the global Veterinary Pharmaceutical Drugs Market research for this analysis based on animal type, key players, drivers, etc.

By Animal Type:

  • Production
  • Companio

By Product:

  • Biologics
  • Pharmaceuticals
  • Medicated Feed Additives

By Regions:

  • Americas
  • Europe
  • Asia-Pacific
  • The Middle East and Africa

Frequently Asked Questions (FAQs)

The global veterinary pharmaceuticals drugs market was worth USD 41,633.76 million during 2020 and is expected to reach USD 64,796.09 million by 2026 at a CAGR of 7.56%. 
North America is expected to hold the highest market share in Veterinary Pharmaceutical Drugs Market.
In 2020 Global Veterinary Pharmaceutical Drugs Market was valued at USD 41,633.76 million.
Boehringer Ingelheim International GmbH, Zoetis, Bayer AG, Elanco, Merck & Co. Inc., Virbac, Dechra Veterniary Products, Ceva, Vetoquinol India Animal Health Pvt. Ltd are the top players in Veterinary Pharmaceutical Drugs Market.
Increasing consumption of pork and beef meat across the globe are the key factor expected to drive the Veterinary Pharmaceutical Drugs Market during forecast period.

Copyright . All rights Reserved By Straits Research